SPRY1 and rhabdomyosarcoma: These findings are in agreement with other studies that showed that Spry1 suppression led to reduction in EMT in breast cancer8 and colorectal cancer50, and potently inhibited cell proliferation and survival of embryonal rhabdomyosarcoma subtype tumors29.